| From
Discovery to Licensure: The Informatics Continuum
Live Q&A session will
immediately follow
Early-stage research applications take on the
flavor of the clinical world and the nuances
associated with pulling together clinical trials
information for the purpose of developing a
submission. However, as the arc of research
enters late stage development, the informatics
needs undergo a chameleon-like transformation
to resemble a mainstream QC architecture. This
discussion will center on the changing informatics
needs associated with this continuum, and the
intricate integration and project/program management
planning tasks that are attendant to the complexity
of this transformation.
Discussion Topics/Panelists
:
Problems Encountered and Solutions
Developed when Integrating Data from Drug Discovery
and Development Environments
David Sedlock
Ph.D., Director of Informatics
Millennium Pharmaceuticals
The basis for advancing the drug discovery
and development pipeline in the pharma industry
is the ability to make informed decisions associated
with the management of the various projects
created to guide the R&D process. These
decisions are impacted significantly by the
ability to review, assess, analyze and report
data associated with the multitude of tests
that are conducted for these drug candidates.
This presentation will review the various approaches
used at Millennium to aid this effort and will
discuss a roadmap that we have developed to
guide the evolution of our research and development
informatics systems.
David Sedlock is
currently the Director of Informatics at Millennium
Pharmaceuticals. He is responsible for the development
and management of the informatics environment
supporting the drug discovery and preclinical
development activities at Millennium. This includes
application development, deployment, integration
and support for the informatics platform supporting
R&D activities. David received his Ph.D.
in Bacteriology/Biochemistry from the University
of Wisconsin, Madison, and has been working
in the pharmaceutical and biotech industries
for the past 25 years. He has been responsible
for drug discovery/development and informatics
programs during much of this time, with experience
both in small molecule and natural product compound
management, testing and advancement as drug
candidates, as well as the development and deployment
of software systems to manage this process.
Moderator:
Randy C. Hice
President
Laboratory Expertise Center
Randy C. Hice is
the president and CEO of Laboratory Expertise
Center, Inc. (LEC), a laboratory automation
consulting firm. Randy has worked in laboratory
automation for 20+ years, and first developed
laboratory workflow analysis in 1989. Prior
to working with LEC, Randy was a software and
business consultant for LIMS for Digital Equipment
Corporation. Randy's activities at LEC include
global strategic analysis for large-scale LIMS
and laboratory automation initiatives. He also
directs a team of LEC consultants who perform
laboratory workflow analysis, LIMS user requirements
development, system selection, and LIMS project
design and implementation. Randy also is a contributing
monthly editor on laboratory data management
for Scientific Computing magazine and a member
of the publication's editorial board.
|